BE533913A - - Google Patents
Info
- Publication number
- BE533913A BE533913A BE533913DA BE533913A BE 533913 A BE533913 A BE 533913A BE 533913D A BE533913D A BE 533913DA BE 533913 A BE533913 A BE 533913A
- Authority
- BE
- Belgium
- Prior art keywords
- amino acids
- parts
- ascorbic acid
- process according
- ether
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/62—Three oxygen atoms, e.g. ascorbic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fodder In General (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE533913A true BE533913A (enrdf_load_stackoverflow) |
Family
ID=165460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE533913D BE533913A (enrdf_load_stackoverflow) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE533913A (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1207374B (de) * | 1962-08-16 | 1965-12-23 | Merck Ag E | Verfahren zur Erhoehung der Bestaendigkeit von fester 1-Ascorbinsaeure |
-
0
- BE BE533913D patent/BE533913A/fr unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1207374B (de) * | 1962-08-16 | 1965-12-23 | Merck Ag E | Verfahren zur Erhoehung der Bestaendigkeit von fester 1-Ascorbinsaeure |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1203242A (fr) | Procede de preparation de sels derives de l'acide 3- hydroxybutanoique et d'une base organique aminee, et les sels ainsi obtenus | |
| CH469659A (fr) | Procédé d'obtention de dérivés du tri-hydroxy-méthyl-aminométhane | |
| FR2460672A1 (fr) | Preparation de poudre d'acetylsalicylate pour injection | |
| CA1312333C (fr) | Sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant | |
| BE533913A (enrdf_load_stackoverflow) | ||
| FR2556727A1 (fr) | Nouvelles compositions therapeutiques a base d'adn a haut poids moleculaire et leur procede de preparation | |
| FR2492821A1 (fr) | Derives de la pyrimidine, leur procede de preparation et les compositions pharmaceutiques les contenant | |
| CH651032A5 (fr) | Phenoxyisobutyrates de moroxydine et medicaments les contenant. | |
| BE1000157A5 (fr) | Procede de preparation de derives de la moranoline. | |
| EP0005422B1 (fr) | Dérivés d'acides oméga-dialkylalkanoiques, leurs procédés de préparation ainsi que leur utilisation en thérapeutique | |
| CA1095067A (fr) | Sels d'hydrocarbyl-thio-ethylamines et leurs applications | |
| JP2006265202A (ja) | α−リポ酸アミノ酸塩 | |
| CA2193096C (fr) | Derives de l'acide guanylique et applications comme medicaments | |
| FR2528840A1 (fr) | N-(3-(4-(3-fluorobenzyloxy) phenoxy)propyl) morpholine, son procede de preparation et son application en therapeutique | |
| FR2503153A1 (fr) | Butyrylaminoacides. mode de preparation. emploi dans les domaines cosmetique, hygienique, therapeutique et agricole | |
| FR2491471A1 (fr) | Benzoxazolinones substituees, leur preparation et leur application en therapeutique | |
| CH294897A (fr) | Procédé pour la préparation de l'acide 5,6,7, 8-tétrahydro-10-formyl-ptéroyl-glutamique. | |
| BE445966A (enrdf_load_stackoverflow) | ||
| BE572026A (enrdf_load_stackoverflow) | ||
| BE887220A (fr) | Compositions antitumeurs | |
| BE535182A (enrdf_load_stackoverflow) | ||
| BE574132A (enrdf_load_stackoverflow) | ||
| BE530472A (enrdf_load_stackoverflow) | ||
| BE482003A (enrdf_load_stackoverflow) | ||
| FR2475546A1 (fr) | Phenoxyisobutyrates de moroxydine et medicaments les contenant |